Logo image of CANS.CA

WILDPACK BEVERAGE INC (CANS.CA) Stock Fundamental Analysis

TSX-V:CANS - TSX Venture Exchange - CA96812Y1016 - Common Stock - Currency: CAD

0.005  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CANS. CANS was compared to 12 industry peers in the Beverages industry. CANS has a bad profitability rating. Also its financial health evaluation is rather negative. CANS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CANS had negative earnings in the past year.
CANS had a negative operating cash flow in the past year.
CANS had negative earnings in each of the past 5 years.
CANS had a negative operating cash flow in each of the past 5 years.
CANS.CA Yearly Net Income VS EBIT VS OCF VS FCFCANS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

The Return On Assets of CANS (-122.12%) is worse than 75.00% of its industry peers.
Industry RankSector Rank
ROA -122.12%
ROE N/A
ROIC N/A
ROA(3y)-79.88%
ROA(5y)-56.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CANS.CA Yearly ROA, ROE, ROICCANS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

CANS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CANS.CA Yearly Profit, Operating, Gross MarginsCANS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

More info and screens

0

2. Health

2.1 Basic Checks

CANS does not have a ROIC to compare to the WACC, probably because it is not profitable.
CANS has about the same amout of shares outstanding than it did 1 year ago.
CANS has a worse debt/assets ratio than last year.
CANS.CA Yearly Shares OutstandingCANS.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CANS.CA Yearly Total Debt VS Total AssetsCANS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

CANS has an Altman-Z score of -7.70. This is a bad value and indicates that CANS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CANS (-7.70) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.7
ROIC/WACCN/A
WACC0.18%
CANS.CA Yearly LT Debt VS Equity VS FCFCANS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

2.3 Liquidity

A Current Ratio of 0.13 indicates that CANS may have some problems paying its short term obligations.
CANS's Current ratio of 0.13 is on the low side compared to the rest of the industry. CANS is outperformed by 83.33% of its industry peers.
A Quick Ratio of 0.10 indicates that CANS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.10, CANS is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.1
CANS.CA Yearly Current Assets VS Current LiabilitesCANS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

CANS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -84.86%.
The Revenue has grown by 12.31% in the past year. This is quite good.
Measured over the past years, CANS shows a very strong growth in Revenue. The Revenue has been growing by 25.06% on average per year.
EPS 1Y (TTM)-84.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.68%
Revenue 1Y (TTM)12.31%
Revenue growth 3Y25.06%
Revenue growth 5YN/A
Sales Q2Q%55.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y150%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year48.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CANS.CA Yearly Revenue VS EstimatesCANS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 50M 100M 150M
CANS.CA Yearly EPS VS EstimatesCANS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 -0.1 -0.2 -0.3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CANS. In the last year negative earnings were reported.
CANS is valuated cheaply with a Price/Forward Earnings ratio of 0.12.
Based on the Price/Forward Earnings ratio, CANS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, CANS is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.12
CANS.CA Price Earnings VS Forward Price EarningsCANS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CANS.CA Per share dataCANS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

CANS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CANS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WILDPACK BEVERAGE INC

TSX-V:CANS (7/10/2025, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)N/A N/A
Inst Owners5.95%
Inst Owner ChangeN/A
Ins Owners27.88%
Ins Owner ChangeN/A
Market Cap500.90K
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.12
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)0.04
Fwd EY829.53%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.84
BVpS-1.1
TBVpS-1.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -122.12%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-79.88%
ROA(5y)-56.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.87%
Cap/Sales 0.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.1
Altman-Z -7.7
F-Score3
WACC0.18%
ROIC/WACCN/A
Cap/Depr(3y)16.37%
Cap/Depr(5y)54.85%
Cap/Sales(3y)1.96%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-84.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.68%
EPS Next Y150%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.31%
Revenue growth 3Y25.06%
Revenue growth 5YN/A
Sales Q2Q%55.94%
Revenue Next Year48.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1399.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2780.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1486.36%
OCF growth 3YN/A
OCF growth 5YN/A